NovaBridge Biosciences (NBP) Other Operating Expenses (2024 - 2025)
NovaBridge Biosciences (NBP) reported Other Operating Expenses of -$174.0 million for Q4 2025, down 143.85% year-over-year from $396.9 million in Q4 2024, and down 1100.8% on a QoQ basis from -$14.5 million in Q3 2025.
NovaBridge Biosciences (NBP) has 2 years of Other Operating Expenses data on file, last reported at -$174.0 million in Q4 2025.
- Quarterly Other Operating Expenses fell 143.85% year-over-year to -$174.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$188.5 million (down 164.16% YoY) and the FY2025 annual result came in at -$188.5 million, down 83.31% from the prior year.
- Other Operating Expenses fell to -$174.0 million in Q4 2025 per NBP's latest filing, from -$14.5 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at -$14.5 million in Q3 2025 and bottomed at -$174.0 million in Q4 2025.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -174.04 Mn |
| Sep 30, 2025 | -14.49 Mn |
| Dec 31, 2024 | -71.37 Mn |